N/A N=396 Implementing BREASTChoice Into Practice
Breast Reconstruction · Breast Cancer
Primary: Knowledge as Measured by Decision Quality Instrument — 66.7; 66.7 score on a scale — p=0.801
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=120 Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach
Breast Cancer
Primary: Percent Correct on the Knowledge Measure (Objective Knowledge Score) — 84.6; 59.7 percentage of answers correct
N/A N=36 Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction
Surgical Incision
Primary: Patient and Observer Scar Assessment Scale (POSAS)- Patient Scores 12M — 1.09; 1.22; 1.3; 1.87 score on a scale
Phase 2 N=47 Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction
Breast Cancer
Primary: Quality of Recovery Score — 165; 169 score on a scale
Phase 3 N=104 Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer
Rectal Cancer
Primary: 30-day Uncomplicated Perineal Wound Healing — 30; 33 Participants
N/A N=50 Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)
Breast Cancer · Breast Reconstruction · Nipple Reconstruction
Primary: Percent Nipple Projection at 12 Months Compared to Baseline (1 Week Post-procedure) — 37.3 percentage of projection vs baseline
N/A N=41 Decision Support Workshop for Breast Reconstruction
Breast Cancer
Primary: Decision Self-efficacy Scale — 5.7; 5.1 units on a scale
N/A N=150 Biomechanical Reconstruction of Three Different Hip Stem Designs in Hip Dysplasia Using a 3D CT-based Planning Software
Dysplasia; Hip
Primary: Correct Reconstruction CLS — 138 Hips
N/A N=54 Postoperative Virtual Clinical Encounters
Pelvic Organ Prolapse
Primary: Patient Satisfaction Via the Patient Satisfaction Questionnaire -18 — 80.7; 81.2 score on a scale
Phase 2 N=110 Enoxaparin Metabolism in Reconstructive Surgery Patients
Venous Thromboembolism · Deep Venous Thrombosis · Pulmonary Embolus
Primary: Number of Participants With Venous Thromboembolism Events — 5; 0 Participants
Phase 4 N=44 Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)
Pain Management
Primary: Narcotic Use — 8; 6.75 MME
N/A N=62 The Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction
Breast Reconstruction
Primary: Postoperative Duration of Drain Placements — 9.2; 10.8 days — p=0.15
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
N/A N=20 A Study to Evaluate the Results of Facial Soft Tissue Reconstruction in Patients Who Have Suffered Traumatic Injury
Facial Injuries · Adipose Tissue
Primary: Volume — 0.576; 0.621 milliliters
N/A N=20 Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction
Breast Cancer
Primary: Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant — 8; 12 Participants
N/A N=201 Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants
Breast Implantation
Primary: Percentage of Subjects With First Reoperation Following Use of a BIOCELL™ Textured 410 Implant — 28 Percentage of Subjects
N/A N=90 Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
Breast Cancer
Primary: Number of Participants With Complications After Tissue Expander Replacement With Implant — 10; 10 participants
N/A N=32 Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT
Breast Cancer
Primary: Success Rate — 65.4 percentage of participants
N/A N=100 3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery
Hypomastia · Primary Breast Augmentation
Primary: Breast Q Augmentation Module — 494.5; 503.4; 420 units on a scale
N/A N=5 Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort
Facial Injuries · Adipose Tissue
Primary: Facial Volume Score — 1.8; 2.2; 2.2; 2.6 units on a scale
N/A N=100 The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe
Soft Tissue Support and Repair
Primary: Investigator Satisfaction With Seri® Surgical Scaffold on an 11-Point Scale — 8.8 Scores on a Scale
N/A N=198 One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure
Breast Cancer
Primary: BreastQ Quality of Life and Satisfaction Questionnaire — 65.32; 67.07 score on a scale — p=0.05
N/A N=26 The PreOperative Management of Patients Awaiting Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament Injuries · Anterior Cruciate Ligament Rupture · Rehabilitation
Primary: Number of Participants Who Completed Semi-structured Interviews — 18; 0; 8; 12 Participants
Phase 4 N=60 PEMF and PEC Blocks in Mastectomy Reconstruction Patients
Breast Cancer Female
Primary: Score on Visual Analog Scale (VAS) - 1 Hour Post-intervention — 6.64; 6.67; 4.62; 6.93 score on a scale
N/A N=24 A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair
Hernia, Ventral
Primary: The Frequency of Hernia Recurrence Diagnosed by Physical Exam or CT Scan (if Clinically Indicated) — 1 Participants
N/A N=142 A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty
Breast Augmentation · Breast Reconstruction
Primary: Reoperation Rates — 6 participants
N/A N=58 Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
Vaginal Vault Prolapse · Pelvic Organ Prolapse · Uterine Prolapse
Primary: Patient Global Impression of Improvement (PGI-I) Score — 39 Participants
N/A N=139 The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
Breast Reconstruction
Primary: Investigator Satisfaction Following Use of SERI® Surgical Scaffold at 6 Months — 9.4 units on a scale
N/A N=19,872 Perioperative Morbidity in Elective Surgery Based on the Time of the Year
Perioperative Complication
Primary: Percentage of Surgical Complication — 3513 Participants
N/A N=698 Pelvic Floor Repair Systems for Prolapse Repair
Pelvic Organ Prolapse
Primary: Percent of Subjects With an ICS (International Incontinence Society) POP-Q (Pelvic Organ Prolapse Quantification System) Stage of </= Stage I in the Posterior…